On September 24, the American Heart Association and American College of Cardiology simultaneously published an updated joint guideline in Circulation and JACC addressing cardiovascular evaluation and management of patients before, during, and after noncardiac surgery.
Advertisement
The initiative is promoting lung cancer screening and efforts to fund research, as well as releasing an upcoming report.
A novel endothelin receptor type A selective antagonist showed a meaningful reduction in proteinuria in patients with IgAN.
Novo Nordisk will terminate development of ocedurenone for treatment of hypertension in chronic kidney disease.
A Mendelian randomized analysis was performed to determine the effects of anti-CD20 antibodies on endometrial cancer.
The Kidney Transplant Collaborative called on CMS to prioritize the IOTA payment model to improve transplant access.
Using X-Therma preservation products, a pig kidney preserved at subzero temperatures survived a transatlantic flight.
Two pivotal trials—EARLY TAVR and EVOLVED—were presented, each exploring early intervention in asymptomatic severe AS.
Researchers conducted an extensive analysis of PM2.5 exposure based on residential history, satellite data, and more.
DocWire Content Partners
Gain insights from The CardioNerds, a group of cardiology experts who aim to democratize cardiovascular education.
Fundamentals, core concepts, and important management approaches in the field of hematology and oncology
Dr. Chadi Nabhan, a renowned voice in hematology and oncology, tackles a multitude of relevant health care topics.
Drs. Rohit Gosain and Rahul Gosain discuss practice-changing data and standards of oncology care.
Dr. Hady Lichaa is an interventional cardiologist specializing in complex coronary interventions.
Review important issues in the rheumatology space, including lupus, rheumatoid arthritis, and more, from Dr. Maheswaranathan.
Powered by DocWire News
The Latest From GI Oncology Now
In several different types of cancer, tumor budding is linked to poor survival outcomes.
The phase III study found that regorafenib improved overall survival in patients with refractory advanced gastric cancer.
Study participants were administered nadunolimab with a standard dose of gemcitabine and nab-paclitaxel (GN) every two weeks.
The SOX chemotherapy regimen for gastric cancer consists of S-1, an oral fluoropyrimidine, in combination with oxaliplatin.
Repeated use of TACE can impair liver function and stimulate tumor angiogenesis.
Dr. Richard Finn provides an overview of the key studies in liver cancer from ESMO 2024.
The Latest From Heme Today
Clinicians seek alternatives to biopsy for clinically evaluating bone marrow mutations in cytopenic patients.
A retrospective study's insights help inform timing decisions regarding allogenic HCT in patients with MDS or CMML.
Investigators examined patients' baseline transfusion burdens and erythropoietin levels for correlations with agent response.
The COMMANDS trial data underscore luspatercept as the preferred treatment for disease not previously exposed to ESAs.
A cohort lifetime study from Hamda Khan, MA, and Jason Hodges, PhD, MA, follows patients from pediatric into adult SCD care.
A phase II trial evaluated use of the thrombopoietin receptor agonist in patients with at least one prior therapy.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.